A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants with Huntington¿s Disease
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Sage Therapeutics
Start Date
March 3, 2022
End Date
July 23, 2025
Administered By
Neurology, Movement Disorders
Awarded By
Sage Therapeutics
Start Date
March 3, 2022
End Date
July 23, 2025